Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvalent Inc | 5,269,433 | 5,269,433 | 0 | $402.06M | $455.70M | 13.48% | +$53.64M |
| Merus N V | 4,281,954 | 4,373,770 | +91,816 | $225.23M | $411.79M | 12.18% | +$186.56M |
| Arcellx Inc COMMON STOCK | 4,649,016 | 4,649,016 | 0 | $306.14M | $381.68M | 11.29% | +$75.55M |
| Revolution Medicines, Inc.(RVMD) | 6,093,291 | 6,223,291 | +130,000 | $224.17M | $290.63M | 8.60% | +$66.46M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 2,976,099 | 2,665,698 | -310,401 | $120.56M | $158.42M | 4.69% | +$37.86M |
| Vaxcyte, Inc.(PCVX) | 3,372,837 | 3,784,755 | +411,918 | $109.65M | $136.33M | 4.03% | +$26.68M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 1,564,196 | +1,564,196 | $0 | $132.80M | 3.93% | +$132.80M |
| Genmab A/SADS(GMAB) | 0 | 3,816,851 | +3,816,851 | $0 | $117.06M | 3.46% | +$117.06M |
| Agios Pharmaceuticals, Inc.(AGIO) | 1,142,511 | 2,673,555 | +1,531,044 | $38.00M | $107.32M | 3.18% | +$69.32M |
| Crinetics Pharmaceuticals In | 2,343,553 | 2,550,774 | +207,221 | $67.40M | $106.24M | 3.14% | +$38.84M |
| Edgewise Therapeutics, Inc.(EWTX) | 6,142,344 | 6,170,131 | +27,787 | $80.53M | $100.08M | 2.96% | +$19.55M |
| Cidara Therapeutics Inc | 0 | 961,164 | +961,164 | $0 | $92.04M | 2.72% | +$92.04M |
| UroGen Pharma Ltd.(URGN) | 0 | 4,216,084 | +4,216,084 | $0 | $84.11M | 2.49% | +$84.11M |
| Scholar Rock Holding Corporation(SRRK) | 1,600,554 | 2,009,745 | +409,191 | $56.69M | $74.84M | 2.21% | +$18.15M |
| Janux Therapeutics, Inc.(JANX) | 2,920,258 | 2,920,258 | 0 | $67.46M | $71.37M | 2.11% | +$3.91M |
| Olema Pharmaceuticals, Inc.(OLMA) | 6,764,172 | 6,794,172 | +30,000 | $28.82M | $66.51M | 1.97% | +$37.70M |
| Apogee Therapeutics Inc | 958,630 | 1,521,757 | +563,127 | $41.63M | $60.46M | 1.79% | +$18.83M |
| Viridian Therapeutics, Inc.(VRDN) | 2,741,576 | 2,609,353 | -132,223 | $38.33M | $56.31M | 1.67% | +$17.98M |
| Alkermes plcSHS(ALKS) | 1,375,569 | 1,719,334 | +343,765 | $39.36M | $51.58M | 1.53% | +$12.22M |
| LENZ Therapeutics, Inc.(LENZ) | 1,717,066 | 1,073,461 | -643,605 | $50.33M | $50.00M | 1.48% | -$325.4K |
| Pharvaris N V COM | 1,062,911 | 1,835,494 | +772,583 | $18.71M | $45.80M | 1.36% | +$27.09M |
| Cogent Biosciences, Inc.(COGT) | 10,352,449 | 3,156,398 | -7,196,051 | $74.33M | $45.33M | 1.34% | -$29.00M |
| Ocular Therapeutix, Inc.(OCUL) | 3,420,340 | 3,497,307 | +76,967 | $31.74M | $40.88M | 1.21% | +$9.14M |
| BridgeBio Pharma, Inc.(BBIO) | 965,764 | 684,277 | -281,487 | $41.70M | $35.54M | 1.05% | -$6.16M |
| Erasca, Inc.(ERAS) | 11,907,182 | 13,560,017 | +1,652,835 | $15.12M | $29.56M | 0.87% | +$14.44M |
| EyePoint, Inc.(EYPT) | 0 | 2,005,365 | +2,005,365 | $0 | $28.56M | 0.84% | +$28.56M |
| Tango Therapeutics, Inc.(TNGX) | 0 | 3,086,184 | +3,086,184 | $0 | $25.92M | 0.77% | +$25.92M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 1,900,000 | +1,900,000 | $0 | $25.82M | 0.76% | +$25.82M |
| Spyre Therapeutics, Inc.(SYRE) | 1,870,445 | 1,467,266 | -403,179 | $28.00M | $24.59M | 0.73% | -$3.41M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 1,898,950 | +1,898,950 | $0 | $24.02M | 0.71% | +$24.02M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 1,866,141 | +1,866,141 | $0 | $21.61M | 0.64% | +$21.61M |
| Disc Medicine, Inc.(IRON) | 1,210,971 | 247,716 | -963,255 | $64.13M | $16.37M | 0.48% | -$47.76M |
| Structure Therapeutics IncADS | 0 | 372,869 | +372,869 | $0 | $10.44M | 0.31% | +$10.44M |
| BeOne Medicines AGADS(ONC) | 347,787 | 0 | -347,787 | $84.19M | $0 | — | -$84.19M |
| Crescent Biopharma, Inc.(CBIO) | 642,721 | 0 | -642,721 | $10.37M | $0 | — | -$10.37M |
| Immatics N.V.SHS(IMTX) | 3,144,157 | 0 | -3,144,157 | $16.92M | $0 | — | -$16.92M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 878,323 | 0 | -878,323 | $41.46M | $0 | — | -$41.46M |
| Y-Mabs Therapeutics Inc | 4,236,346 | 0 | -4,236,346 | $19.11M | $0 | — | -$19.11M |